Prognosis Ohio | Relief for Cancer Patients: OSU's Dr. Benjamin Kaffenberger on an Ongoing Derma...
top of page
Newsroom
On the new Prognosis Ohio, part of the WCBE Podcast Experience, Dan Skinner talks with OSU dermatologist and researcher, Benjamin...
May 3, 2021
Empowered Patient I Targeted Cancer Supportive Care Agent for Skin Toxicities with OnQuality
By Karen Jagoda Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the...
Apr 7, 2021
BioWorld | Onquality raises combined $35M for cancer supportive care pipeline
By David Ho HONG KONG – Onquality Pharmaceuticals LLC raised an additional $20 million from a series A+ financing round, bringing its...
Mar 31, 2021
WSJ Pro Venture Capital I VC Daily: Startups Use Technology to Help Drugmakers Bring More Diverse
By Brian Gormley Good day. Venture-backed companies are using technology to help drugmakers bring more diverse populations of patients...
Mar 31, 2021
OnQuality Pharmaceuticals Announces Closing of $35 Million Series A and A+ Financing
SEATTLE and SHANGHAI—March 31, 2021. OnQuality Pharmaceuticals LLC ("OnQuality"), a targeted cancer supportive care company developing me...
Mar 30, 2021
BioSpace I OnQuality Pharma Raises $20 Million to Support Ongoing Oncodermatology Trial
By Gail Dutton OnQuality Pharmaceuticals just raised $20 million in Series A+ funding to support its Phase II oncodermatology trial. The...
Mar 30, 2021
BioWorld I Financings for March 31, 2021
Biopharmas raising money in public or private financings, including: 9 Meters, Achilles, Celsion, Design, Edgewise, Humanigen, Ikena, New...
Mar 18, 2021
Life Science Leader I How A New Biopharma CEO Approaches Diversity & Inclusion
By Rob Wright Michael McCullar, Ph.D., who joined OnQuality Pharmaceuticals as the company’s CEO in Dec. 2020, shares thoughts on his...
Aug 14, 2020
OnQuality Pharmaceuticals Announces Enrollment of First Patient in a Phase II Study to Evaluate...
Seattle, WA—August 14, 2020. OnQuality Pharmaceuticals (USA) LLC, dedicated to the discovery and development of therapies to improve qua...
Oct 27, 2019
OnQuality raises $15 million in series A financing
Shanghai, China—Oct. 28th, 2019. OnQuality Pharmaceuticals Ltd., a start-up pharmaceutical company focusing on mitigating on-target toxic...
bottom of page